LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer

被引:0
|
作者
Li-yuan Feng
Yong-zhi Huang
Wei Zhang
Li Li
机构
[1] Guangxi Medical University Cancer Hospital,Department of Gynecologic Oncology
[2] Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor,undefined
[3] Ministry of Education,undefined
关键词
Ovarian cancer; Chemoresistance ; LAMA3 methylation; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer
    Feng, Li-yuan
    Huang, Yong-zhi
    Zhang, Wei
    Li, Li
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [2] DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
    Lund, Riikka J.
    Huhtinen, Kaisa
    Salmi, Jussi
    Rantala, Juha
    Nguyen, Elizabeth V.
    Moulder, Robert
    Goodlett, David R.
    Lahesmaa, Riitta
    Carpen, Olli
    SCIENTIFIC REPORTS, 2017, 7
  • [3] DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer
    Riikka J. Lund
    Kaisa Huhtinen
    Jussi Salmi
    Juha Rantala
    Elizabeth V. Nguyen
    Robert Moulder
    David R. Goodlett
    Riitta Lahesmaa
    Olli Carpén
    Scientific Reports, 7
  • [4] Correlation of LAMA3 with onset and prognosis of ovarian cancer
    Tang, Lin
    Wang, Pin
    Wang, Qilin
    Zhong, Lan
    ONCOLOGY LETTERS, 2019, 18 (03) : 2813 - 2818
  • [5] DNA methylation characteristics associated with chemotherapy resistance in epithelial ovarian cancer
    Duan, Changling
    Yan, Zhongxin
    Wu, Cailiang
    Zhou, Xuexin
    Bao, Wei
    HELIYON, 2024, 10 (05)
  • [6] Alterations in DNA methylation patterns associated with onset of chemotherapy resistance in ovarian cancer
    Montgomery, John S.
    Balch, Curtis
    Mand, Mike
    Kim, Yoo-Sung
    Paik, Henry H.
    Kim, Sun
    Huang, Tim H-M.
    Nephew, Kenneth P.
    CANCER RESEARCH, 2006, 66 (08)
  • [7] Identification of enhancer methylation associated with resistance of ovarian cancer after neoadjuvant chemotherapy
    Ebata, Takahrio
    Yamashita, Satoshi
    Yoshida, Hiroshi
    Kato, Tomoyasu
    Ushijima, Toshikazu
    CANCER SCIENCE, 2021, 112 : 332 - 332
  • [8] DNA methylation of markers associated with response to chemotherapy in tumor and plasma DNA of ovarian cancer patients
    Hall, Jacqueline A.
    Teodoridis, Jens M.
    Evans, Elizabeth
    Paul, Jim
    Brown, Robert
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer
    Flanagan, James M.
    Wilson, Angela
    Koo, Chail
    Masrour, Nahal
    Gallon, John
    Loomis, Erick
    Flower, Kirsty
    Wilhelm-Benartzi, Charlotte
    Hergovich, Alexander
    Cunnea, Paula
    Gabra, Hani
    Braicu, Elena Ioana
    Sehouli, Jalid
    Darb-Esfahani, Silvia
    Vanderstichele, Adriaan
    Vergote, Ignace
    Kreuzinger, Caroline
    Castillo-Tong, Dan Cacsire
    Wisman, G. Bea A.
    Berns, Els Mjj
    Siddiqui, Nadeem
    Paul, James
    Brown, Robert
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2213 - 2222
  • [10] DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival
    Pedersen, Christine Aaserod
    Cao, Maria Dung
    Fleischer, Thomas
    Rye, Morten B.
    Knappskog, Stian
    Eikesdal, Hans Petter
    Lonning, Per Eystein
    Tost, Jorg
    Kristensen, Vessela N.
    Tessem, May-Britt
    Giskeodegard, Guro F.
    Bathen, Tone F.
    BREAST CANCER RESEARCH, 2022, 24 (01)